Health Canada will reportedly approve Pfizer-BioNTech’s COVID-19 vaccine for children aged five to 11 on Friday. At this time, official confirmation of this information is pending.
An alternate media source, citing multiple sources, reported the update on Wednesday evening.
The report indicates that a delivery of around three million pediatric doses is expected in the coming days, which would be enough for every single eligible child in that age group to receive one dose of the vaccine.
Pfizer-BioNTech submitted its youth vaccine data for review on Oct. 18.
The company recently released data from its own study, which found the vaccine is nearly 91 per cent effective at preventing symptomatic infections in kids aged five to 11.
Last month, Canada signed a deal with Pfizer to secure 2.9 million doses of its COVID-19 vaccine for kids, which would be shipped upon Health Canada’s approval.
“These deliveries will provide sufficient supply to provide a first dose to every eligible Canadian child,” Procurement Minister Anita Anand said at the time.
The Pfizer vaccine is sold under the name Comirnaty. The one for children uses the same mRNA technology as the one for adults but in a smaller dosage. The doses are about one-third the size given to adults and teens aged 12 and up.
Earlier this week, Health Canada received a submission from Moderna to approve its mRNA COVID-19 vaccine for use among children aged six to 11.
–with files from toronto.citynews.ca